LIVIVO - Search results -

Search results

Result 1 - 10 of total 311

Search options

Article ; Online: Subsequent pregnancy in women who have undergone bilateral uterine artery ligation during cesarean section: A case series.

An, Jian

2023 Volume 27, Issue 1, Page(s) 9

Abstract: Bilateral uterine artery ligation (BUAL) serves as an effective surgical devascularization procedure in obstetric emergencies. However, concerns regarding the impact of uterine devascularization have evoked dispute. Here, the fetal growth index and ... ...

Abstract	Bilateral uterine artery ligation (BUAL) serves as an effective surgical devascularization procedure in obstetric emergencies. However, concerns regarding the impact of uterine devascularization have evoked dispute. Here, the fetal growth index and obstetrical outcomes during the subsequent pregnancy of women who had undergone BUAL during cesarean section are reported. The case series of women who underwent BUAL during cesarean section and had another delivery later at the Xiamen Women and Children's Hospital between 2011 and 2020 is described. Pregnancies that did not continue beyond 20 weeks of gestation were excluded. Cases were identified from neonatal and obstetric databases and the clinical data of all cases were extracted. A total of 12 cases were identified retrospectively. Fetal biometric parameters of subsequent pregnancies in all cases including biparietal diameter, head circumference, abdominal circumference, and femur length are presented graphically across the different gestational ages and were all within the range of the 3rd-97th percentile. No maternal or neonatal morbidity was observed. BUAL did not appear to compromise a woman's subsequent obstetric outcomes. As a safe and simple surgical technique, it is safe to recommend BUAL in clinical practice.
Language	English
Publishing date	2023-11-13
Publishing country	Greece
Document type	Case Reports
ZDB-ID	2683844-8
ISSN	1792-1015 ; 1792-0981
ISSN (online)	1792-1015
ISSN	1792-0981
DOI	10.3892/etm.2023.12296
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Possible layered lithospheric anisotropy around Longmenshan Faults by teleseismic S wave splitting and receiver functions

An-Jian Wang / Yuan Gao

Frontiers in Earth Science, Vol

2024 Volume 11

Abstract: This study conducts an in-depth analysis of seismic anisotropy around the Longmenshan Faults. Utilizing a dataset of about 7710 earthquake catalogs from July 2007 to March 2023, we applied S wave splitting and receiver function methods to examine Pms and ...

Abstract	This study conducts an in-depth analysis of seismic anisotropy around the Longmenshan Faults. Utilizing a dataset of about 7710 earthquake catalogs from July 2007 to March 2023, we applied S wave splitting and receiver function methods to examine Pms and XKS waveforms collected from 12 fixed broadband stations across Gansu and Sichuan provinces. Our analysis revealed significant variations in seismic anisotropy between the crust and lithosphere, marked by distinct fast wave directions and delay times. These characteristics point to the possibility for layered anisotropy within the region. A two-layer anisotropy inversion analysis at key stations further delineated the differential anisotropic behaviors between the crust and the upper mantle, underscoring the impact of local geological structures and mantle dynamics. Crucially, our study posits the existence of layered anisotropy around the Longmenshan Fault Zone, a finding that significantly advances our comprehension of the region’s seismic anisotropy and adds a vital dimension to our understanding of its subsurface structural intricacies and tectonic evolution.
Keywords	anisotropy ; teleseismic S wave splitting ; lithospheric deformation ; receiver fuctions ; longmenshan faults ; Science ; Q
Subject code	550
Language	English
Publishing date	2024-01-01T00:00:00Z
Publisher	Frontiers Media S.A.
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Clinical efficacy of thermocoagulation in women with biopsy-confirmed cervical low-grade squamous intraepithelial lesions (LSILs) or less after colposcopy referral.

Chen, Xiaoying / An, Jian / Zhu, Jianfang

Ginekologia polska

2023 Volume 94, Issue 7, Page(s) 511–517

Abstract: Objectives: To evaluate the clinical efficacy of thermocoagulation in women with biopsy-confirmed cervical low-grade squamous intraepithelial lesions (LSIL) or less after colposcopy referral.: Material and methods: A longitudinal study was performed. ...

Abstract	Objectives: To evaluate the clinical efficacy of thermocoagulation in women with biopsy-confirmed cervical low-grade squamous intraepithelial lesions (LSIL) or less after colposcopy referral. Material and methods: A longitudinal study was performed. Women who were diagnosed with cervical LSIL or chronic cervicitis underwent scheduled follow-up examinations with cytology and human papilloma virus (HPV) genotyping for two years after the initial management with thermocoagulation or observation without treatment. All women underwent scheduled follow-up with combined cytology and HPV test at 6th months, 12th months, and 24th months after the initial management. Both HPV clearance and cytological regression were included in the analysis, with clinical cure defined as normal cytology and negative HPV results. Results: A total of 221 women were included. The histopathological results identified 136 (61.54%) patients with LSIL and 85 (38.46%) with chronic cervicitis. Of these, 113 (51.13%) received thermocoagulation therapy, and 108 (48.87%) chose observation. The 2-year follow-up rate was 91.40%. Women who received thermocoagulation presented a significantly higher probability of cure for two years than those who chose observation (62.86% vs 39.18%, p < 0.001). This preponderance was not observed in the subgroup analysis regarding women with cervical cervicitis (54.17% vs 41.38%, p = 0.277) but was observed in women with LSILs (70.18% vs 38.24%, p < 0.001). Conclusions: Thermocoagulation may be indicated for patients with cervical LSILs as an effective outpatient procedure in clinical practice.
MeSH term(s)	Female ; Humans ; Pregnancy ; Biopsy ; Colposcopy ; Electrocoagulation/adverse effects ; Human Papillomavirus Viruses/genetics ; Longitudinal Studies ; Papillomavirus Infections ; Referral and Consultation ; Squamous Intraepithelial Lesions/pathology ; Squamous Intraepithelial Lesions/surgery ; Treatment Outcome ; Uterine Cervicitis/pathology ; Adult
Language	English
Publishing date	2023-08-03
Publishing country	Poland
Document type	Journal Article
ZDB-ID	130894-4
ISSN	2543-6767 ; 0017-0011
ISSN (online)	2543-6767
ISSN	0017-0011
DOI	10.5603/GP.a2022.0055
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 118: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Thermal Activation of High-Alumina Coal Gangue Auxiliary Cementitious Admixture: Thermal Transformation, Calcining Product Formation and Mechanical Properties.

Zhang, Mingjun / Li, Liang / Yang, Fan / Zhang, Shigang / Zhang, He / Zhu, Yongfu / An, Jian

Materials (Basel, Switzerland)

2024 Volume 17, Issue 2

Abstract: In this paper, a new preparation technology is developed to make high-alumina coal gangue (HACG) auxiliary cementitious admixture by calcining HACG-Ca(OH) ...

Abstract	In this paper, a new preparation technology is developed to make high-alumina coal gangue (HACG) auxiliary cementitious admixture by calcining HACG-Ca(OH)
Language	English
Publishing date	2024-01-14
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2487261-1
ISSN	1996-1944
ISSN	1996-1944
DOI	10.3390/ma17020415
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Pattern recognition of microcirculation with super-resolution ultrasound imaging provides markers for early tumor response to anti-angiogenic therapy.

Yin, Jingyi / Dong, Feihong / An, Jian / Guo, Tianyu / Cheng, Heping / Zhang, Jiabin / Zhang, Jue

Theranostics

2024 Volume 14, Issue 3, Page(s) 1312–1324

Abstract: Rationale: ...

Abstract	Rationale:
MeSH term(s)	Humans ; Microcirculation ; Neoplasms/blood supply ; Ultrasonography/methods ; Treatment Outcome ; Immunotherapy ; Microvessels/diagnostic imaging ; Microbubbles
Language	English
Publishing date	2024-01-20
Publishing country	Australia
Document type	Journal Article
ZDB-ID	2592097-2
ISSN	1838-7640 ; 1838-7640
ISSN (online)	1838-7640
ISSN	1838-7640
DOI	10.7150/thno.89306
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Apple E3 ligase MdPUB23 mediates ubiquitin-dependent degradation of MdABI5 to delay ABA-triggered leaf senescence.

Yang, Fei / Zhao, Ling-Ling / Song, Lai-Qing / Han, Yuepeng / You, Chun-Xiang / An, Jian-Ping

Horticulture research

2024 Volume 11, Issue 4, Page(s) uhae029

Abstract: ABSCISIC ACID-INSENSITIVE5 (ABI5) is a core regulatory factor that mediates the ABA signaling response and leaf senescence. However, the molecular mechanism underlying the synergistic regulation of leaf senescence by ABI5 with interacting partners and ... ...

Abstract	ABSCISIC ACID-INSENSITIVE5 (ABI5) is a core regulatory factor that mediates the ABA signaling response and leaf senescence. However, the molecular mechanism underlying the synergistic regulation of leaf senescence by ABI5 with interacting partners and the homeostasis of ABI5 in the ABA signaling response remain to be further investigated. In this study, we found that the accelerated effect of MdABI5 on leaf senescence is partly dependent on MdbHLH93, an activator of leaf senescence in apple. MdABI5 directly interacted with MdbHLH93 and improved the transcriptional activation of the senescence-associated gene
Language	English
Publishing date	2024-01-30
Publishing country	England
Document type	Journal Article
ISSN	2662-6810
ISSN	2662-6810
DOI	10.1093/hr/uhae029
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: Efficacy and safety of bivalirudin bridging enoxaparin versus fondaparinux in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: evidence from a single-center study.

Guo, Yanqing / Wang, Jingping / Wang, Zhixin / Li, Li / An, Jian

Archives of medical science : AMS

2023 Volume 19, Issue 1, Page(s) 242–249

Abstract: Introduction: This study aims to compare the safety and efficacy of bivalirudin bridging enoxaparin versus fondaparinux in patients with acute myocardial infarction (AMI) who were undergoing primary percutaneous coronary intervention (PPCI).: Methods!# ...

Abstract	Introduction: This study aims to compare the safety and efficacy of bivalirudin bridging enoxaparin versus fondaparinux in patients with acute myocardial infarction (AMI) who were undergoing primary percutaneous coronary intervention (PPCI). Methods: The study is a prospective, natural, and selective interventional trial based on real-world data for 482 AMI patients. Results: At the end of the follow-up, the two groups demonstrated similar major adverse cardiovascular and cerebrovascular events (MACCE) and bleeding rates. After propensity score matching (PSM), the fondaparinux group showed greater advantages in reducing MACCE and bleeding events. Conclusions: The anticoagulation strategy of bivalirudin bridging fondaparinux seems to be superior to that of bivalirudin bridging enoxaparin in patients with AMI undergoing PPCI.
Language	English
Publishing date	2023-01-13
Publishing country	Poland
Document type	Journal Article
ZDB-ID	2203781-0
ISSN	1734-1922
ISSN	1734-1922
DOI	10.5114/aoms/157287
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Evaluation of different doses of Femoston therapy for incomplete abortion: A prospective observational trial.

Wang, Wenrong / Gong, Bingchen / Cai, Yingying / Huang, Xueyao / An, Jian

Medicine

2023 Volume 102, Issue 43, Page(s) e35415

Abstract: This study aimed to compare the efficacy of different doses of femoston with expectant management in patients with incomplete abortions. Patients diagnosed with incomplete abortion were included if they chose to continue medical treatment after relevant ... ...

Abstract	This study aimed to compare the efficacy of different doses of femoston with expectant management in patients with incomplete abortions. Patients diagnosed with incomplete abortion were included if they chose to continue medical treatment after relevant contraindications were excluded. Participants were divided into 3 groups: the femoston (1/10) and femoston (2/10) groups received different doses of femoston, and patients in the control group received expectant treatment. The success rate of complete abortion and the rate of menstrual recovery among the 3 groups were compared to evaluate the efficacy of different doses of femoston in patients with incomplete abortions. A total of 197 patients were analyzed: 73 in the femoston (1/10) group, 73 in the femoston (2/10) group, and 51 patients were followed up without treatment in the control group. The femoston group was significantly more effective than the control group P < .0001). The adjusted odds ratio (OR) and 95% confidence interval (CI) were 3.103 and 1.153 to 8.350 (P = .025). The success rate of complete abortion in the femoston (2/10) group was significantly higher than that in the femoston (1/10) group (adjusted OR: 0.403, 95% CI: 0.145-1.118, P = .081). In addition, the rate of menstrual recovery in the femoston group was significantly higher than that in the control group (P = .007), and the rate in the femoston (2/10) group was also higher than the femoston (1/10) group with statistically significant (P = .001). Femoston is effective in treating incomplete abortion, with femostons containing 2 mg estrogen being more effective. Patients with incomplete abortion are treated with femoston, and menstrual recovery time may be shortened. Femostons may be a new option for pharmacological treatment of incomplete abortions.
MeSH term(s)	Female ; Humans ; Pregnancy ; Abortion, Incomplete/drug therapy ; Abortion, Incomplete/etiology ; Abortion, Induced ; Abortion, Spontaneous/epidemiology ; Abortion, Spontaneous/etiology ; Estradiol
Chemical Substances	Estradiol (4TI98Z838E) ; femoston
Language	English
Publishing date	2023-11-01
Publishing country	United States
Document type	Clinical Trial ; Journal Article ; Observational Study
ZDB-ID	80184-7
ISSN	1536-5964 ; 0025-7974
ISSN (online)	1536-5964
ISSN	0025-7974
DOI	10.1097/MD.0000000000035415
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.171: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Two Types of Wear Mechanisms Governing Transition between Mild and Severe Wear in Ti-6Al-4V Alloy during Dry Sliding at Temperatures of 20-250 °C.

Du, Danhu / Zhang, Wenbin / An, Jian

Materials (Basel, Switzerland)

2022 Volume 15, Issue 4

Abstract: Dry wear characteristics and wear mechanisms governing mild-severe wear transition of Ti-6Al-4V alloy were studied during sliding against medium carbon chromium steel (50Cr) in an experimental temperature range of 20-250 °C. At each experimental ... ...

Abstract	Dry wear characteristics and wear mechanisms governing mild-severe wear transition of Ti-6Al-4V alloy were studied during sliding against medium carbon chromium steel (50Cr) in an experimental temperature range of 20-250 °C. At each experimental temperature, wear rate was plotted against applied load, and its variation was broken into two stages according to the difference of slope. Morphologies and contents of worn surfaces were examined by scanning electron microscope and energy dispersive X-ray spectrometer, from which the two stages were identified to correspond to mild and severe wear, respectively. Two types of wear mechanisms that dominated mild-severe wear transition were found, i.e., breakdown of mechanically mixed layer at temperatures of 20 and 50 °C, and severe plastic deformation at temperatures of 100-250 °C. Microstructures and hardness were examined in the subsurfaces, from which severe plastic deformation-dominated mild-severe wear transition was identified to be caused by the softening arising from friction heating-induced dynamic recrystallization. A linear relation between mild-severe wear transition load and experimental temperature was discovered. The intercept of experimental temperature axis 450 °C was obtained by linearly fitting, and it was considered as a critical dynamic recrystallzation temperature for mild-severe wear transition within the temperature range of 100-250 °C.
Language	English
Publishing date	2022-02-14
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2487261-1
ISSN	1996-1944
ISSN	1996-1944
DOI	10.3390/ma15041416
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases.

Wang, Zhenhong / An, Jian / Wang, Chaohua

BMC women's health

2022 Volume 22, Issue 1, Page(s) 436

Abstract: Objective: Administration of GnRH agonist (GnRHa) prior to chemotherapy may decreases the risk of gonadal dysfunction in patients with tumors. However, relevant data in haematopoietic stem cell transplantation (HSCT) recipients has not yet been ... ...

Abstract	Objective: Administration of GnRH agonist (GnRHa) prior to chemotherapy may decreases the risk of gonadal dysfunction in patients with tumors. However, relevant data in haematopoietic stem cell transplantation (HSCT) recipients has not yet been established. Hence, the present study was designed to evaluate the clinical efficacy of GnRHa cotreatment prior to myeloablative regimens on ovarian protection in female survivors of HSCT for haematological diseases. Patients and methods: Eligible patients were divided into a GnRHa group and a control group. Medical records regarding age at HSCT; diagnosis/indication for HSCT; pre- and posttransplantation serum sex hormone levels; menstruation and perimenopausal symptoms after HSCT were collected and compared. The primary and secondary outcome was the incidence of premature ovarian insufficiency (POI) symptoms associated with hypoestrogenism. Results: A total of 330 patients were enrolled in the study: 19 patients were lost to follow-up, and clinical information was obtained in 311 patients. There was no significant difference in the primary outcome of follow-up between the two groups (78.50% [84 of 107] for the GnRHa group versus 83.33% [170 of 204] for the control group). The adjusted relative risks (RR) and 95% confidence interval (CI) were 1.19 and 0.73-1.93 (P = 0.487). Among patients who received cotreatment with GnRHa, 62.62% (67 of 107) complained of perimenopausal symptoms, which was significantly lower than the 74.51% (152 of 204) in the control group (adjusted RR: 1.46, 95% CI: 1.04-2.06, P = 0.031). Conclusion: GnRHa cotreatment may not decrease the POI rate in HSCT survivors. However, it may reduce perimenopausal symptoms in this population, suggesting a potential benefit of GnRHa in clinical practice and warrant further researches.
MeSH term(s)	Humans ; Female ; Gonadotropin-Releasing Hormone/therapeutic use ; Primary Ovarian Insufficiency/prevention & control ; Primary Ovarian Insufficiency/epidemiology ; Menopause, Premature ; Hematologic Diseases/drug therapy ; Hematopoietic Stem Cell Transplantation/adverse effects ; Survivors
Chemical Substances	Gonadotropin-Releasing Hormone (33515-09-2)
Language	English
Publishing date	2022-11-07
Publishing country	England
Document type	Journal Article
ZDB-ID	2050444-5
ISSN	1472-6874 ; 1472-6874
ISSN (online)	1472-6874
ISSN	1472-6874
DOI	10.1186/s12905-022-02039-8
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

To top

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito